Microtubule defects in mesenchymal stromal cells distinguish patients with Progressive Supranuclear Palsy-Reference-Cited by-同舟云学术

Microtubule defects in mesenchymal stromal cells distinguish patients with Progressive Supranuclear Palsy

Published:2018-03-04 Issue:5 Volume:22 Page:2670-2679
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Calogero Alessandra Maria¹,Viganò Mariele²,Budelli Silvia²³,Galimberti Daniela⁴,Fenoglio Chiara⁴,Cartelli Daniele¹,Lazzari Lorenza²,Lehenkari Petri⁵,Canesi Margherita³,Giordano Rosaria²,Cappelletti Graziella¹⁶^ORCID,Pezzoli Gianni³

Affiliation:

1. Department of Biosciences Università degli Studi di Milano Milan Italy

2. Department of Services and Preventive Medicine Laboratory of Regenerative Medicine ‐ Cell Factory Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy

3. Parkinson Institute ASST G.Pini‐CTO, ex ICP Milan Italy

4. Department of Physiopathology and Transplantation Dino Ferrari Center Neurodegenerative Disease Unit Fondazione Ca' Granda IRCCS Ospedale Policlinico University of Milan Milan Italy

5. Department of Surgery and Anatomy Medical Research Center University of Oulu and University of Oulu Hospital Oulu Finland

6. Center of Excellence on Neurodegenerative Diseases Università degli Studi di Milano Milan Italy

Funder

Fondazione Grigioni per il Morbo di Parkinson

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.13545

Reference49 articles.

1. Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia. A clinical report on eight cases of “Heterogenous system degeneration”;Richardson J;Trans Am Neurol Assoc,1963

2. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.

3. Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches

4. Progressive Supranuclear Palsy: What Do We Know About it?

5. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Graphene monolayer as an appropriate substrate for mesenchymal stem cells support in regenerative medicine;Indian Journal of Experimental Biology;2023-03-31

2. Safety and Effectiveness of Cell Therapy in Neurodegenerative Diseases: Take-Home Messages From a Pilot Feasibility Phase I Study of Progressive Supranuclear Palsy;Frontiers in Neuroscience;2021-10-12

3. Preliminary Evaluations of [11C]Verubulin: Implications for Microtubule Imaging With PET;Frontiers in Neuroscience;2021-09-08

4. Novel Therapies for Parkinsonian Syndromes–Recent Progress and Future Perspectives;Frontiers in Molecular Neuroscience;2021-08-26

5. Microtubule-targeting agents and neurodegeneration;Drug Discovery Today;2021-02